References
- 1. Olszewski, R., Timperley, J., Szmigielski, C., Monaghan, M., Nihoyannopoulos, P., Senior, R., & Becher, H. (2007). The clinical applications of contrast echocardiography. Eur J Echocardiogr, 8(3), S13-23. doi:10.1016/j.euje.2007.03.02110.1016/j.euje.2007.03.021
- 2. Mulvagh, S. L., Rakowski, H., Vannan, M. A., Abdelmoneim, S. S., Becher, H., Bierig, S. M., Burns, P. N., Castello, R., Coon, P. D., Hagen, M. E., Jollis, J. G., Kimball, T. R., Kitzman, D. W., Kronzon, I., Labovitz, A. J., Lang, R. M., Mathew, J., Moir, W. S., Nagueh, S. F., Pearlman, A. S., Perez, J. E., Porter, T. R., Rosenbloom, J., Strachan, G. M., Thanigaraj, S., Wei, K., Woo, A., Yu, E. H., Zoghbi, W. A., & American Society of, E. (2008). American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr, 21(11), 1179-1201; quiz 1281. doi:10.1016/j.echo.2008.09.00910.1016/j.echo.2008.09.009
- 3. Weissman, N. J., Cohen, M. C., Hack, T. C., Gillam, L. D., Cohen, J. L., & Kitzman, D. W. (2000). Infusion versus bolus contrast echocardiography: a multicenter, open-label, crossover trial. Am Heart J, 139(3), 399-404.10.1016/S0002-8703(00)90082-6
- 4. Thanigaraj, S., Nease, R. F., Jr., Schechtman, K. B., Wade, R. L., Loslo, S., & Perez, J. E. (2001). Use of contrast for image enhancement during stress echocardiography is cost-effective and reduces additional diagnostic testing. Am J Cardiol, 87(12), 1430-1432.10.1016/S0002-9149(01)01573-9
- 5. Senior, R., Becher, H., Monaghan, M., Agati, L., Zamorano, J., Vanoverschelde, J. L., & Nihoyannopoulos, P. (2009). Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography. Eur J Echocardiogr, 10(2), 194-212. doi:10.1093/ejechocard/jep00510.1093/ejechocard/jep005
- 6. Mulvagh, S. L., DeMaria, A. N., Feinstein, S. B., Burns, P. N., Kaul, S., Miller, J. G., Monaghan, M., Porter, T. R., Shaw, L. J., & Villanueva, F. S. (2000). Contrast echocardiography: current and future applications. J Am Soc Echocardiogr, 13(4), 331-342.10.1067/mje.2000.105462
- 7. Quaia, E. (2006). Contrast Media in Ultrasonography: Basic Principles and Clinical Applications: Springer Berlin Heidelberg.
- 8. Gramiak, R., & Shah, P. M. (1968). Echocardiography of the aortic root. Invest Radiol, 3(5), 356-366.10.1097/00004424-196809000-00011
- 9. Feinstein, S. B., Shah, P. M., Bing, R. J., Meerbaum, S., Corday, E., Chang, B. L., Santillan, G., & Fujibayashi, Y. (1984). Microbubble dynamics visualized in the intact capillary circulation. J Am Coll Cardiol, 4(3), 595-600..10.1016/S0735-1097(84)80107-2
- 10. Shapiro, J. R., Reisner, S. A., Lichtenberg, G. S., & Meltzer, R. S. (1990). Intravenous contrast echocardiography with use of sonicated albumin in humans: systolic disappearance of left ventricular contrast after transpulmonary transmission. J Am Coll Cardiol, 16(7), 1603-1607..10.1016/0735-1097(90)90308-C
- 11. Feinstein, S. B., Cheirif, J., Ten Cate, F. J., Silverman, P. R., Heidenreich, P. A., Dick, C., Desir, R. M., Armstrong, W. F., Quinones, M. A., & Shah, P. M. (1990). Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol, 16(2), 316-324.10.1016/0735-1097(90)90580-I
- 12. Schlief, R., Staks, T., Mahler, M., Rufer, M., Fritzsch, T., & Seifert, W. (1990). Successful opacification of the left heart chambers on echocardiographic examination after intravenous injection of a new saccharide based contrast agent. Echocardiography, 7(1), 61-64.10.1111/j.1540-8175.1990.tb00349.x
- 13. Beppu, S., Matsuda, H., Shishido, T., Matsumura, M., & Miyatake, K. (1997). Prolonged myocardial contrast echocardiography via peripheral venous administration of QW3600 injection (EchoGen): its efficacy and side effects. J Am Soc Echocardiogr, 10(1), 11-2410.1016/S0894-7317(97)80028-4
- 14. GE Healthcare. (2008). OPTISON prescribing Information. Retrieved from http://www.amershamhealth-us.com/optison/
- 15. Skyba, D. M., Camarano, G., Goodman, N. C., Price, R. J., Skalak, T. C., & Kaul, S. (1996). Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol, 28(5), 1292-1300. doi:10.1016/S0735-1097(96)00328-210.1016/S0735-1097(96)00328-2
- 16. Luminity Summary of Product Characteristics. (2008). Retrieved from http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000654/WC500045020.pdf
- 17. Definity-FDA prescribing information, side effects and uses (2001). Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021064s011lbl.pdf
- 18. Sontum, P. C. (2008). Physicochemical characteristics of Sonazoid, a new contrast agent for ultrasound imaging. Ultrasound Med Biol, 34(5), 824-833. doi:10.1016/j.ultrasmedbio.2007.11.00610.1016/j.ultrasmedbio.2007.11.00618255220
- 19. SonoVue INN-sulphur hexafluoride- European Medicines Agency (2014). Retrieved from www.ema.europa.eu
- 20. Dolan, M. S., Gala, S. S., Dodla, S., Abdelmoneim, S. S., Xie, F., Cloutier, D., Bierig, M., Mulvagh, S. L., Porter, T. R., & Labovitz, A. J. (2009). Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. J Am Coll Cardiol, 53(1), 32-38. doi:10.1016/j.jacc.2008.08.06610.1016/j.jacc.2008.08.06619118722
- 21. Main, M. L., Goldman, J. H., & Grayburn, P. A. (2007). Thinking outside the “box”-the ultrasound contrast controversy. J Am Coll Cardiol, 50(25), 2434-2437. doi:10.1016/j.jacc.2007.11.00610.1016/j.jacc.2007.11.00618154971
- 22. Main, M. L., Hibberd, M. G., Ryan, A., Lowe, T. J., Miller, P., & Bhat, G. (2014). Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent. JACC Cardiovasc Imaging, 7(1), 40-48. doi:10.1016/j.jcmg.2013.08.012.10.1016/j.jcmg.2013.08.01224290568
- 23. EMEA. Scientific Discussion. European Medicines Agency. (2004). Retrieved from CPMP/0053/01.http://www.emea.europa.eu/humandocs/human/epar/sonovue/sonovue.htm
- 24. Van Camp, G., Droogmans, S., & Cosyns, B. (2007). Bio-effects of ultrasound contrast agents in daily clinical practice: fact or fiction?†. European Heart Journal, 28(10), 1190-1192. doi:10.1093/eurheartj/ehm11010.1093/eurheartj/ehm11017470674
- 25. EMEA. http://www.emea.europa.eu/, document reference: Emea/cpmp/212/04
- 26. Porter, T. R., Abdelmoneim, S., Belcik, J. T., McCulloch, M. L., Mulvagh, S. L., Olson, J. J., Porcelli, C., Tsutsui, J. M., & Wei, K. (2014). Guidelines for the cardiac sonographer in the performance of contrast echocardiography: a focused update from the American Society of Echocardiography. J Am Soc Echocardiogr, 27(8), 797-810. doi:10.1016/j.echo.2014.05.01110.1016/j.echo.2014.05.01125085408
- 27. Cosyns, B., Pasquet, A., Van Camp, G., Hernot, S., Droogmans, S., Unger, P., De Sutter, J., Lancellotti, P., & Belgian Working Group on Non-Invasive Cardiac, I. (2009). Safety of ultrasound contrast agents: “Primum non nocere”? Acta Cardiol, 64(4), 547-552. doi:10.2143/AC.64.4.204162210.2143/AC.64.4.204162219725450
- 28. Schinkel, A. F., Kaspar, M., & Staub, D. (2015) Contrast-enhanced ultrasound: clinical applications in patients with atherosclerosis. Int J Cardiovasc Imaging. Advance online publication.10.1007/s10554-015-0713-z470684126206524
- 29. Amyot, R., Morales, M. A., & Rovai, D. (2000). Contrast echocardiography for myocardial perfusion imaging using intravenous agents: progress and promises. Eur J Echocardiogr, 1(4), 233-243. doi:10.1053/euje.2000.003610.1053/euje.2000.003611916600
- 30. Abdelmoneim, S. S., Bernier, M., Scott, C. G., Dhoble, A., Ness, S. A., Hagen, M. E., Moir, S., McCully, R. B., Pellikka, P. A., & Mulvagh, S. L. (2009). Safety of contrast agent use during stress echocardiography: a 4-year experience from a single-center cohort study of 26,774 patients. JACC Cardiovasc Imaging, 2(9), 1048-1056. doi:10.1016/j.jcmg.2009.03.02010.1016/j.jcmg.2009.03.02019761981
- 31. Malhotra, V., Nwogu, J., Bondmass, M. D., Bean, M., Bieniarz, T., Tertell, M., Conliss, M., & Devries, S. (2000). Is the technically limited echocardiographic study an endangered species? endocardial border definition with native tissue harmonic imaging and Optison contrast: a review of 200 cases. J Am Soc Echocardiogr, 13(8), 771-773.10.1067/mje.2000.10607810936821
- 32. Rainbird, A. J., Mulvagh, S. L., Oh, J. K., McCully, R. B., Klarich, K. W., Shub, C., Mahoney, D. W., & Pellikka, P. A. (2001). Contrast dobutamine stress echocardiography: clinical practice assessment in 300 consecutive patients. J Am Soc Echocardiogr, 14(5), 378-385.10.1067/mje.2001.11126411337683
- 33. Shah, B. N., Chahal, N. S., Bhattacharyya, S., Li, W., Roussin, I., Khattar, R. S., & Senior, R. (2014). The feasibility and clinical utility of myocardial contrast echocardiography in clinical practice: results from the incorporation of myocardial perfusion assessment into clinical testing with stress echocardiography study. J Am Soc Echocardiogr, 27(5), 520-530. doi:10.1016/j.echo.2014.01.02810.1016/j.echo.2014.01.02824637056